AuroShell particle infusion

DEVICE2 trials

Sponsors

Nanospectra Biosciences, Inc.

Conditions

Neoplasms of the Prostate

Unknown Phase

MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue

CompletedNCT02680535

Nanospectra Biosciences, Inc.Neoplasms of the Prostate

Start: 2016-02-29End: 2020-10-31Updated: 2021-03-03

An Extension Study MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue

Nanospectra Biosciences, Inc.Neoplasms of the Prostate

Start: 2020-01-30End: 2023-06-30Target: 60Updated: 2023-05-18

Related Papers

Novel Automated Three-Dimensional Surgical Planning Tool and Magnetic Resonance Imaging/Ultrasound Fusion Technology to Perform Nanoparticle Ablation and Cryoablation of the Prostate for Focal Therapy

Journal of Endourology2021-08-1917 citations

PD17-11 PHASE II CLINICAL TRIAL: SHORT-TERM ONCOLOGIC OUTCOMES OF NANOPARTICLE-DIRECTED FOCAL PHOTOTHERMAL LASER ABLATION

The Journal of Urology2020-04-013 citations

PD65-04 MR/US FUSION GUIDED ULTRA-FOCAL GOLD NANOPARTICLE DIRECTED LASER ABLATION OF PROSTATE TUMORS: RESULTS IN THE FIRST 11 PATIENTS (PHASE I/II TRIAL)

The Journal of Urology2018-04-011 citations